DIABETOGENICITY OF FK506 VERSUS CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS

被引：5
|
作者：
JINDAL, RM [1 ]
POPESCU, I [1 ]
SCHWARTZ, ME [1 ]
EMRE, S [1 ]
BOCCAGNI, P [1 ]
MILLER, CM [1 ]
机构：
[1] MT SINAI MED CTR,DIV LIVER TRANSPLANTAT,NEW YORK,NY 10029
来源：
TRANSPLANTATION | 1994年 / 58卷 / 03期
关键词：
D O I：
10.1097/00007890-199408000-00021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：370 / 372
页数：3
相关论文
共 50 条
  • [31] INFECTIONS IN ADULT LIVER-TRANSPLANT PATIENTS UNDER FK506 IMMUNOSUPPRESSION
    ALESSIANI, M
    KUSNE, S
    MARTIN, M
    JAIN, A
    ABUELMAGD, K
    MOSER, J
    TODO, S
    FUNG, J
    STARZL, T
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1501 - 1503
  • [32] Kaposi's sarcoma in liver transplant recipients on FK506
    Kadry, Z
    Bronsther, O
    Fung, JJ
    [J]. TRANSPLANTATION, 1998, 65 (08) : 1140 - 1140
  • [33] HISTOLOGIC DIFFERENCES OF ACUTE CELLULAR REJECTION IN LIVER-TRANSPLANT RECIPIENTS ON FK-506 AND CYCLOSPORINE-A
    HYTIROGLOU, P
    LEE, R
    SHARMA, K
    THEISE, N
    SCHWARTZ, M
    MILLER, C
    THUNG, SN
    [J]. LABORATORY INVESTIGATION, 1992, 66 (01) : A97 - A97
  • [34] GASTROINTESTINAL TOXICITY ASSOCIATED WITH FK-506 IN LIVER-TRANSPLANT RECIPIENTS
    FISHER, A
    SCHWARTZ, M
    MOR, E
    SHEINER, P
    EMRE, S
    GUY, S
    MILLER, C
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3106 - 3107
  • [35] Tacrolimus (FK506) versus cyclosporine microemulsion (Neoral) as maintenance immunosuppression therapy in kidney transplant recipients
    Abou-Jaoude, MM
    Najm, R
    Shaheen, J
    Nawfal, N
    Abboud, S
    AlHabash, M
    Darwish, M
    Mulhem, A
    Ojjeh, A
    Almawi, WY
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3025 - 3028
  • [36] THE EFFECT OF FOOD ON ORAL BIOAVAILABILITY OF TACROLIMUS (FK506) IN LIVER-TRANSPLANT PATIENTS
    MEKKI, Q
    LEE, C
    CARRIER, S
    KLINTMAIM, G
    SHAEFER, M
    BURKE, P
    SCHECHTER, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 229 - 229
  • [37] Interaction of cyclosporine and FK506 with diuretics in transplant patients
    Arthur, JM
    Shamim, S
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 325 - 330
  • [38] Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience
    Selzner, N
    Durand, F
    Bernuau, J
    Heneghan, MA
    Tuttle-Newhall, JE
    Belghiti, J
    Clavien, PA
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1061 - 1065
  • [39] FK506 HEPATOTOXICITY IN LIVER ALLOGRAFT RECIPIENTS
    FISHER, A
    MOR, E
    HYTIROGLOU, P
    EMRE, S
    BOCCAGNI, P
    CHODOFF, L
    SHEINER, P
    SCHWARTZ, M
    THUNG, SN
    MILLER, C
    [J]. TRANSPLANTATION, 1995, 59 (11) : 1631 - 1632
  • [40] Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: Potential implications in transplant arteriopathy
    Freudenberger, R
    Alexis, J
    Gass, A
    Fuster, V
    Badimon, J
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (12): : 1228 - 1231
12345